Cost Effectiveness of Pharmacogenomic Testing for Simvastatin

A discrete event simulation model for evaluation of clinical benefit and costs-effectiveness of utilizing pharmacogenomic testing in Simvastatin treatement

Probabilities

Costs in Dollars

Population

TODO: Currently a fixed age. Will be modified soon to reflect actual population distribution at Vanderbilt

Simulation Results

Numbers are given in 25% 50% 75% quantiles

Quality Adjusted Life In Sim Histogram

Costs

No Testing

With Genotyping

Counts

No Testing

With Genotyping

Simulation Method

Built using R with the simmer and shiny packages.

TODO: Website footer here